116 related articles for article (PubMed ID: 19575773)
21. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
[TBL] [Abstract][Full Text] [Related]
22. Medical management of Peyronie's disease.
Hellstrom WJ
J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
[TBL] [Abstract][Full Text] [Related]
23. Intralesional verapamil for the treatment of Peyronie's disease: a review.
Levine LA; Estrada CR
Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
[TBL] [Abstract][Full Text] [Related]
24. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Gallo L; Sarnacchiaro P
Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797
[TBL] [Abstract][Full Text] [Related]
25. Intralesional recombinant interferon alpha-2b in Peyronie's disease.
Astorga R; Cantero O; Contreras D; del Río-Martín A; Labarta-Beceiro V; Gutiérrez-Elvírez A; Lima-López MA; López-Saura P
Arch Esp Urol; 2000 Sep; 53(7):665-71. PubMed ID: 11037665
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
[TBL] [Abstract][Full Text] [Related]
27. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
Judge IS; Wisniewski ZS
Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
[TBL] [Abstract][Full Text] [Related]
28. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
29. A Primer on the History of Intralesional Verapamil Injection for Peyronie's Disease.
Levine LA
Urology; 2023 Mar; 173():5-7. PubMed ID: 36596363
[No Abstract] [Full Text] [Related]
30. Intralesional verapamil injection for the treatment of Peyronie's disease.
Levine LA; Merrick PF; Lee RC
J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
[TBL] [Abstract][Full Text] [Related]
31. Current approach to the man with acute phase Peyronie's disease--case presentation and discussion.
Levine LA
J Sex Med; 2011 Jun; 8(6):1556-8; quiz 1559. PubMed ID: 21631731
[No Abstract] [Full Text] [Related]
32. Iontophoresis for treatment of Peyronie's disease.
Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
[TBL] [Abstract][Full Text] [Related]
33. Update on medical management of Peyronie's disease.
Tan RB; Sangkum P; Mitchell GC; Hellstrom WJ
Curr Urol Rep; 2014 Jun; 15(6):415. PubMed ID: 24740275
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease.
Andresen R; Wegner HE; Banzer D; Miller K
Acta Radiol; 1996 May; 37(3 Pt 1):352-6. PubMed ID: 8845268
[TBL] [Abstract][Full Text] [Related]
35. [Clinical effects of verapamil in the treatment of Peyronie's disease].
Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
[TBL] [Abstract][Full Text] [Related]
36. Minimally invasive treatment of Peyronie's disease: evidence-based progress.
Jordan GH; Carson CC; Lipshultz LI
BJU Int; 2014 Jul; 114(1):16-24. PubMed ID: 24447536
[TBL] [Abstract][Full Text] [Related]
37. The medical management of Peyronie's disease.
Akin-Olugbade Y; Mulhall JP
Nat Clin Pract Urol; 2007 Feb; 4(2):95-103. PubMed ID: 17287870
[TBL] [Abstract][Full Text] [Related]
38. Surgical and minimally invasive treatments for Peyronie's disease.
Kumar R; Nehra A
Curr Opin Urol; 2009 Nov; 19(6):589-94. PubMed ID: 19741538
[TBL] [Abstract][Full Text] [Related]
39. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease.
Wegner HE; Andresen R; Knispel HH; Miller K
Eur Urol; 1997; 32(2):190-3. PubMed ID: 9286652
[TBL] [Abstract][Full Text] [Related]
40. Peyronie's disease: clinical treatment.
Aita G; Ros CTD; Silvinato A; Bernardo WM
Rev Assoc Med Bras (1992); 2019; 65(10):1231-1239. PubMed ID: 31721953
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
